Matches in SemOpenAlex for { <https://semopenalex.org/work/W2548076162> ?p ?o ?g. }
- W2548076162 endingPage "138" @default.
- W2548076162 startingPage "129" @default.
- W2548076162 abstract "Introduction: Estimation of residual rivaroxaban plasma concentrations may be requested before invasive procedures and some patients at high thromboembolic risk will have a bridging therapy with heparins when rivaroxaban is interrupted. Objective: The objective of this study was to assess the performance of the STA-Liquid Anti-Xa assay (STA LAX) and the low and normal procedures of the Biophen Direct Factor Xa Inhibitors (DiXaI) assay, in patients with and without bridging with low-molecular-weight heparins (LMWHs). Materials and Methods: Seventy-nine blood samples were collected from 77 patients on rivaroxaban at C TROUGH or before an invasive procedure. Rivaroxaban plasma concentrations were estimated using Biophen DiXaI, Biophen DiXaI LOW, and STA LAX and compared to liquid chromatography coupled with mass spectrometry (LC-MS/MS) measurements. Stratifications were performed according to heparin bridging. Results: The Biophen DiXaI LOW and STA LAX showed better correlation with LC-MS/MS measurements than Biophen DiXaI in patients not bridged with LMWH (R: 0.97, 0.96, and 0.91, respectively). However, the performance of Biophen DiXaI LOW and STA LAX decreased when residual LMWH activity was present (R: 0.18 and 0.19 respectively) demonstrating that these tests are not specific to rivaroxaban. Conclusion: In patients not bridged with LMWH, we suggest to use the Biophen DiXaI LOW and STA LAX for the estimation of rivaroxaban concentrations <50 ng/mL. These results should be confirmed on a larger cohort of patients. Patients bridged with LMWH have inaccurate estimates of low levels of rivaroxaban and the 3 assays studied should not be used to estimate if it is safe to perform a procedure." @default.
- W2548076162 created "2016-11-11" @default.
- W2548076162 creator A5000944048 @default.
- W2548076162 creator A5006564157 @default.
- W2548076162 creator A5023392033 @default.
- W2548076162 creator A5041424887 @default.
- W2548076162 creator A5078686392 @default.
- W2548076162 creator A5082941105 @default.
- W2548076162 creator A5086565436 @default.
- W2548076162 creator A5087356922 @default.
- W2548076162 creator A5091294163 @default.
- W2548076162 date "2016-11-03" @default.
- W2548076162 modified "2023-09-26" @default.
- W2548076162 title "Estimation of Rivaroxaban Plasma Concentrations in the Perioperative Setting in Patients With or Without Heparin Bridging" @default.
- W2548076162 cites W1558698055 @default.
- W2548076162 cites W1754932965 @default.
- W2548076162 cites W1762506800 @default.
- W2548076162 cites W1777469538 @default.
- W2548076162 cites W1836026258 @default.
- W2548076162 cites W1837600385 @default.
- W2548076162 cites W1870017071 @default.
- W2548076162 cites W1913131316 @default.
- W2548076162 cites W1913182214 @default.
- W2548076162 cites W1939082786 @default.
- W2548076162 cites W1948257848 @default.
- W2548076162 cites W1969141649 @default.
- W2548076162 cites W1981633543 @default.
- W2548076162 cites W1987976001 @default.
- W2548076162 cites W2000922667 @default.
- W2548076162 cites W2001598988 @default.
- W2548076162 cites W2008944778 @default.
- W2548076162 cites W2016754244 @default.
- W2548076162 cites W2019960723 @default.
- W2548076162 cites W2030594826 @default.
- W2548076162 cites W2045273044 @default.
- W2548076162 cites W2087630384 @default.
- W2548076162 cites W2095214690 @default.
- W2548076162 cites W2114338695 @default.
- W2548076162 cites W2116930113 @default.
- W2548076162 cites W2130467730 @default.
- W2548076162 cites W2132953336 @default.
- W2548076162 cites W2134427191 @default.
- W2548076162 cites W2139887899 @default.
- W2548076162 cites W2147800731 @default.
- W2548076162 cites W2163853479 @default.
- W2548076162 cites W2412757059 @default.
- W2548076162 doi "https://doi.org/10.1177/1076029616675968" @default.
- W2548076162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6714623" @default.
- W2548076162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27811211" @default.
- W2548076162 hasPublicationYear "2016" @default.
- W2548076162 type Work @default.
- W2548076162 sameAs 2548076162 @default.
- W2548076162 citedByCount "21" @default.
- W2548076162 countsByYear W25480761622017 @default.
- W2548076162 countsByYear W25480761622018 @default.
- W2548076162 countsByYear W25480761622019 @default.
- W2548076162 countsByYear W25480761622020 @default.
- W2548076162 countsByYear W25480761622021 @default.
- W2548076162 countsByYear W25480761622022 @default.
- W2548076162 countsByYear W25480761622023 @default.
- W2548076162 crossrefType "journal-article" @default.
- W2548076162 hasAuthorship W2548076162A5000944048 @default.
- W2548076162 hasAuthorship W2548076162A5006564157 @default.
- W2548076162 hasAuthorship W2548076162A5023392033 @default.
- W2548076162 hasAuthorship W2548076162A5041424887 @default.
- W2548076162 hasAuthorship W2548076162A5078686392 @default.
- W2548076162 hasAuthorship W2548076162A5082941105 @default.
- W2548076162 hasAuthorship W2548076162A5086565436 @default.
- W2548076162 hasAuthorship W2548076162A5087356922 @default.
- W2548076162 hasAuthorship W2548076162A5091294163 @default.
- W2548076162 hasBestOaLocation W25480761621 @default.
- W2548076162 hasConcept C126322002 @default.
- W2548076162 hasConcept C174348530 @default.
- W2548076162 hasConcept C185592680 @default.
- W2548076162 hasConcept C2776301958 @default.
- W2548076162 hasConcept C2776884760 @default.
- W2548076162 hasConcept C2777557582 @default.
- W2548076162 hasConcept C2778661090 @default.
- W2548076162 hasConcept C2779161974 @default.
- W2548076162 hasConcept C31258907 @default.
- W2548076162 hasConcept C41008148 @default.
- W2548076162 hasConcept C43617362 @default.
- W2548076162 hasConcept C71924100 @default.
- W2548076162 hasConcept C98274493 @default.
- W2548076162 hasConceptScore W2548076162C126322002 @default.
- W2548076162 hasConceptScore W2548076162C174348530 @default.
- W2548076162 hasConceptScore W2548076162C185592680 @default.
- W2548076162 hasConceptScore W2548076162C2776301958 @default.
- W2548076162 hasConceptScore W2548076162C2776884760 @default.
- W2548076162 hasConceptScore W2548076162C2777557582 @default.
- W2548076162 hasConceptScore W2548076162C2778661090 @default.
- W2548076162 hasConceptScore W2548076162C2779161974 @default.
- W2548076162 hasConceptScore W2548076162C31258907 @default.
- W2548076162 hasConceptScore W2548076162C41008148 @default.
- W2548076162 hasConceptScore W2548076162C43617362 @default.
- W2548076162 hasConceptScore W2548076162C71924100 @default.
- W2548076162 hasConceptScore W2548076162C98274493 @default.
- W2548076162 hasIssue "1" @default.